Complete response to dupilumab in a patient with chronic spontaneous urticaria who did not tolerate omalizumab

Complete response to dupilumab in a patient with chronic spontaneous urticaria who did not tolerate omalizumab

Bibliographic Details
Main Authors:	Changhua Zhu, MD, Jie Shen Fok, MD, Lihang Lin, MD, Huichun Su, MD, Marcus Maurer, MD
Format:	Article
Language:	English
Published:	Elsevier 2023-02-01
Series:	JAAD Case Reports
Subjects:	chronic spontaneous urticaria dupilumab eosinopholia
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352512622005501

Similar Items

Does angioedema in patients with chronic spontaneous urticaria impact response to omalizumab?
by: Thomas B. Casale, MD, et al.
Published: (2024-08-01)

Dupilumab Reduces Urticaria Activity, Itch, and Hives in Patients with Chronic Spontaneous Urticaria Regardless of Baseline Serum Immunoglobulin E Levels
by: Marcus Maurer, et al.
Published: (2024-07-01)

Omalizumab for the management of refractory chronic spontaneous urticaria
by: P C Kathuria, et al.
Published: (2022-01-01)

Therapies for Chronic Spontaneous Urticaria: Present and Future Developments
by: Riccardo Asero, et al.
Published: (2024-11-01)

Omalizumab's efficacy and safety against chronic spontaneous urticaria
by: Öner Özdemir
Published: (2023-08-01)

Efficacy and safety of omalizumab against chronic spontaneous urticaria: Real-world study from China
by: Ao Wang, MD, et al.
Published: (2022-12-01)

Mapping the intellectual structure of the research of omalizumab in chronic spontaneous urticaria: A bibliometric analysis
by: Yuxu Yao, MD, et al.
Published: (2024-05-01)

Omalizumab in the treatment of chronic spontaneous urticaria – literature review and own experience
by: Joanna Dawicka, et al.
Published: (2016-02-01)

Retrospective analysis of the treatment of 61 cases of chronic spontaneous urticaria with omalizumab
by: Shanshan OU, et al.
Published: (2023-04-01)

Omalizumab withdrawal outcomes in chronic spontaneous urticaria are linked with baseline IgE and eosinophil levels
by: Ramit Maoz-Segal, MD, et al.
Published: (2024-05-01)

COVID-19 infection in chronic spontaneous urticaria treated with omalizumab: two case reports
by: Angelo Massimiliano D'Erme, et al.
Published: (2023-08-01)

Clinical observation of desloratadine combined with omalizumab in the treatment of chronic spontaneous urticaria
by: Zhiwei SHANG, et al.
Published: (2022-02-01)

Cyclosporine for omalizumab-refractory chronic urticaria: a report of five cases
by: Anthony F. LaCava, et al.
Published: (2023-08-01)

Omalizumab for Patients with Chronic Spontaneous Urticaria: A Narrative Review of Current Status
by: Thomas B. Casale, et al.
Published: (2023-09-01)

Different doses and courses of omalizumab for patients with chronic spontaneous urticaria: A systematic review with meta-analysis and trial sequential analysis
by: Haiyan Qin, MD, et al.
Published: (2024-04-01)

The impact of home treatment and self-administration of omalizumab on chronic urticaria
by: Anne Christine Wiuff, MBBS, et al.
Published: (2022-12-01)

Efficiency of Adding Omalizumab to Standard Therapy for Children with Recurrent Spontaneous Urticaria: Comparative Observational Study
by: Vera G. Kalugina, et al.
Published: (2020-08-01)

Omalizumab for the treatment of chronic spontaneous urticaria: association between body mass index and outcome
by: Irene Russo, et al.
Published: (2022-10-01)

Treatment of chronic spontaneous urticaria with a single dose of omalizumab: A study of four cases
by: Radhakrishnan Subramaniyan, et al.
Published: (2016-01-01)

Type I and type IIb autoimmune chronic spontaneous urticaria: Using common clinical tools for endotyping patients with CSU
by: Juliana A. Sella, MD, PhD, et al.
Published: (2023-11-01)

Phototherapy as an alternative in the treatment of chronic spontaneous urticaria
by: María Inés Giustozzi, et al.
Published: (2024-11-01)

Urticaria
by: Moshe Ben-Shoshan, et al.
Published: (2024-12-01)

Improving of psychological status and inflammatory biomarkers during omalizumab for chronic spontaneous urticaria
by: Laura Diluvio, et al.
Published: (2020-10-01)

Exploring Machine Learning Techniques to Predict the Response to Omalizumab in Chronic Spontaneous Urticaria
by: Davide Stefano Sardina, et al.
Published: (2021-11-01)

Urticaria and angioedema
by: Amin Kanani, et al.
Published: (2018-09-01)

Omalizumab in Chronic Spontaneous Urticaria: A Real-World Study on Effectiveness, Safety and Predictors of Treatment Outcome
by: Chen J, et al.
Published: (2024-08-01)

A novel case of chronic spontaneous urticaria associated chronic myelogenous leukemia with rapid resolution upon treatment with imatinib
by: Alexis Tracy, MD, et al.
Published: (2022-12-01)

Real-world safety and effectiveness of omalizumab in Japanese patients with chronic spontaneous urticaria: A post-marketing surveillance study
by: Michihiro Hide, et al.
Published: (2023-04-01)

A Practical Approach to Diagnosing and Managing Chronic Spontaneous Urticaria
by: Adam Friedman, et al.
Published: (2024-05-01)

Progress in the application of omalizumab in the treatment of chronic inducible urticaria
by: CHEN Ziyan, et al.
Published: (2024-12-01)

Cytokine Profiles of Chronic Urticaria Patients and the Effects of Omalizumab Treatment
by: Ozge Can Bostan, et al.
Published: (2023-10-01)

Comprehension of the adapted Urticaria Activity Score measure and patient guidance document: qualitative interviews with adults and adolescents with chronic spontaneous urticaria
by: Anne M. Skalicky, et al.
Published: (2024-12-01)

Ligelizumab improves angioedema, disease severity and quality-of-life in patients with chronic spontaneous urticaria
by: Martin Metz, MD, et al.
Published: (2022-11-01)

Advances in the applications of biologics in the treatment of chronic spontaneous urticaria
by: Xuemei HUANG, et al.
Published: (2024-02-01)

Chronic spontaneous urticaria following COVID-19 vaccination
by: Laurence de Montjoye, MD, PhD, et al.
Published: (2022-07-01)

Brain Injury Associated with Chronic Spontaneous Urticaria: a Kounis-Like Syndrome?
by: Luis Santiago, et al.
Published: (2020-01-01)

Long-term Omalizumab Therapy in Patients with Chronic Spontaneous Urticaria: Does it Increase the Risk of COVID-19?
by: Özge Kaya, et al.
Published: (2023-07-01)

Changes of Gut Microbiome in Adolescent Patients with Chronic Spontaneous Urticaria After Omalizumab Treatment
by: Wang M, et al.
Published: (2023-02-01)

In silico Identification of Immune Cell-Types and Pathways Involved in Chronic Spontaneous Urticaria
by: Connor Prosty, et al.
Published: (2022-07-01)

Comparative study of efficacy and safety of cetirizine and bilastine in patients of chronic spontaneous urticaria: Open-label, randomized, parallel-group study
by: Vishakha V Sinha, et al.
Published: (2023-01-01)